Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ingrid Fricke-Galindo

Showing results (1-10 of 49) with videos related to

Pageof 5
Sort By:
Drug Metabolism and Personalized Therapy|September 14, 2023
Relevance of personalized medicine for improving traditional medicineIngrid Fricke-Galindo, Adrián LLerena
Drug Metabolism and Personalized Therapy|January 3, 2024
AncestromicsIngrid Fricke-Galindo, Adrián LLerena
Drug Metabolism and Personalized Therapy|June 3, 2025
Clinical pharmacogenomics guidelines: recommendations in different countries and health care systemsIngrid Fricke-Galindo, Adrián LLerena
Drug Metabolism and Personalized Therapy|December 5, 2023
AncestromicsIngrid Fricke-Galindo, Adrián LLerena
Drug Metabolism and Personalized Therapy|February 21, 2023
News in DMPT: Leaders in Pharmacogenetics SectionIngrid Fricke-Galindo, Adrián LLerena
Drug Metabolism and Personalized Therapy|December 15, 2025
Dr. José María Cantú Garza awardIngrid Fricke-Galindo, Adrián LLerena
Drug Metabolism and Personalized Therapy|August 23, 2023
Relevance of personalized medicine for improving traditional medicineIngrid Fricke-Galindo, Adrián LLerena
Frontiers in Genetics|May 7, 2024
Editorial: The impact of the human genome on interindividual variability in drug responseYaya Kassogue, Ingrid Fricke-Galindo
Pharmacogenomics|April 4, 2023
Exploring the potential benefits of pharmacogenomics in chronic respiratory diseasesIngrid Fricke-Galindo, Ramcés Falfán-Valencia
Expert Review of Respiratory Medicine|November 23, 2022
Current pharmacogenomic recommendations in chronic respiratory diseases: Is there a biomarker ready for clinical implementation?Ingrid Fricke-Galindo, Ramcés Falfán-Valencia
Pageof 5

Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
Drug Metabolism and Personalized Therapy|September 14, 2023
Relevance of personalized medicine for improving traditional medicineIngrid Fricke-Galindo, Adrián LLerena
Drug Metabolism and Personalized Therapy|January 3, 2024
AncestromicsIngrid Fricke-Galindo, Adrián LLerena
Drug Metabolism and Personalized Therapy|June 3, 2025
Clinical pharmacogenomics guidelines: recommendations in different countries and health care systemsIngrid Fricke-Galindo, Adrián LLerena
Drug Metabolism and Personalized Therapy|December 5, 2023
AncestromicsIngrid Fricke-Galindo, Adrián LLerena
Drug Metabolism and Personalized Therapy|February 21, 2023
News in DMPT: Leaders in Pharmacogenetics SectionIngrid Fricke-Galindo, Adrián LLerena
Drug Metabolism and Personalized Therapy|December 15, 2025
Dr. José María Cantú Garza awardIngrid Fricke-Galindo, Adrián LLerena
Drug Metabolism and Personalized Therapy|August 23, 2023
Relevance of personalized medicine for improving traditional medicineIngrid Fricke-Galindo, Adrián LLerena
Frontiers in Genetics|May 7, 2024
Editorial: The impact of the human genome on interindividual variability in drug responseYaya Kassogue, Ingrid Fricke-Galindo
Pharmacogenomics|April 4, 2023
Exploring the potential benefits of pharmacogenomics in chronic respiratory diseasesIngrid Fricke-Galindo, Ramcés Falfán-Valencia
Expert Review of Respiratory Medicine|November 23, 2022
Current pharmacogenomic recommendations in chronic respiratory diseases: Is there a biomarker ready for clinical implementation?Ingrid Fricke-Galindo, Ramcés Falfán-Valencia
Pageof 5